Correlation Between Ensysce Biosciences and OnKure Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and OnKure Therapeutics,, you can compare the effects of market volatilities on Ensysce Biosciences and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and OnKure Therapeutics,.
Diversification Opportunities for Ensysce Biosciences and OnKure Therapeutics,
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ensysce and OnKure is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and OnKure Therapeutics, go up and down completely randomly.
Pair Corralation between Ensysce Biosciences and OnKure Therapeutics,
If you would invest 1,680 in OnKure Therapeutics, on September 3, 2024 and sell it today you would lose (138.00) from holding OnKure Therapeutics, or give up 8.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 0.6% |
| Values | Daily Returns |
Ensysce Biosciences vs. OnKure Therapeutics,
Performance |
| Timeline |
| Ensysce Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| OnKure Therapeutics, |
Ensysce Biosciences and OnKure Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ensysce Biosciences and OnKure Therapeutics,
The main advantage of trading using opposite Ensysce Biosciences and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.| Ensysce Biosciences vs. Ensysce Biosciences | Ensysce Biosciences vs. NRx Pharmaceuticals | Ensysce Biosciences vs. Pasithea Therapeutics Corp | Ensysce Biosciences vs. Faraday Future Intelligent |
| OnKure Therapeutics, vs. Vincerx Pharma | OnKure Therapeutics, vs. Viracta Therapeutics | OnKure Therapeutics, vs. Dogwood Therapeutics, | OnKure Therapeutics, vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |